Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) vs NewcelX Ltd. (NCEL)
Chemomab Therapeutics Ltd. Sponsored ADR and NewcelX Ltd. are both Biotechnology companies. Chemomab Therapeutics Ltd. Sponsored ADR and NewcelX Ltd. are of similar size ($16.0M and $15.6M). Across the 10 metrics below, Chemomab Therapeutics Ltd. Sponsored ADR leads on 5 and NewcelX Ltd. on 5.
Valuation
Profitability
| Metric | CMMB | NCEL | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | — | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (82.17%) | 0.00% | (57.72%) |
| Return on assets | (70.70%) | 0.00% | (49.22%) |
| Return on invested capital | (247.40%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack